<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="letter" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OURD</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-7-112</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20161.31</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A case of purpura annularis telangiectodes of Majocchi</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Keseroglu</surname>
<given-names>Havva Ozge</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>G&#x00F6;n&#x00FC;l</surname>
<given-names>M&#x00FC;zeyyen</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Benar</surname>
<given-names>Hasan</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Unsal</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Department of Dermatology, D&#x0131;&#x015F;kap&#x0131; Y&#x0131;ld&#x0131;r&#x0131;m Beyaz&#x0131;t Education and Research Hospital, 06510, Ankara, Turkey</italic></aff>
<aff id="aff2"><label>2</label><italic>Department of Pathology, D&#x0131;&#x015F;kap&#x0131; Y&#x0131;ld&#x0131;r&#x0131;m Beyaz&#x0131;t Education and Research Hospital, 06510, Ankara, Turkey</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Havva Ozge Keseroglu, E-mail: <email xlink:href="ozgederm@yahoo.com">ozgederm@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2016</year>
</pub-date>
<volume>7</volume>
<issue>1</issue>
<fpage>112</fpage>
<lpage>113</lpage>
<history>
<date date-type="received"><day>30</day><month>03</month><year>2015</year></date>
<date date-type="accepted"><day>01</day><month>06</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 1</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
</article-meta>
</front>
<body>
<sec id="sec1-1">
<title/>
<p>Sir,</p>
<p>Pigmented purpuric dermatoses (PPD) are a group of disorders which have histopathologically similar but morphologically different appearance. The five main clinical subtypes of PPD has been described. The perivascular lymphocytic infiltration of superficial dermal vessels with extravasations of red blood cells are common histopathological characteristics for all types of PPD. The etiopathogenesis of disease remains obscure yet [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. We report a case of purpura annularis telangiectodes of Majocchi (PATM), a very rare type of PPD, with possible drug etiology of diclofenac sodium.</p>
<p>A 52-years-old man presented with asymptomatic skin eruption that had been present for two months. The patient had a history of oral diclofenac sodium intake ten days before the lesions appeared. He also had hepatitis B infection recognized at childhood and he had been followed by gastroenterology department with regular interval. The physical examination revealed several, symmetrical, nonpalpable, nonblanchable, erythematous, annular purpuric patches with a peripheral rim of dark red telangiectatic puncta distributed symmetrically on the upper legs and inguinal areas. The annular patches showed central clearing with minimal hyperpigmentation and atrophy (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>(A) Symmetrical, nonblanchable, erythematous, annular purpuric patches with central clearing and minimal hyperpigmentation and atrophy on the left and (B) inner side of upper leg.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-7-112-g001.tif"/>
</fig>
<p>The laboratory investigations were within normal limits except hepatitis B antigen positivity. The histopathological examination revealed a moderately bandlike infiltration accompanying a prominent perivascular lymphocytic infiltration in superficial dermis. There was no evidence of vasculitis (Figs. <xref ref-type="fig" rid="F2">2A</xref> and <xref ref-type="fig" rid="F2">2B</xref>). Also, hemosiderin deposits was demonsrated within papillary dermis and macrophages by using prussian blue staining (Figs. <xref ref-type="fig" rid="F2">2C</xref> and <xref ref-type="fig" rid="F2">2D</xref>). These findings suggested a diagnosis of pigmented purpuric dermatosis. Together with clinical and histopathological appearance, diagnosis of purpura annularis telangiectodes of Majocchi was made. The drug was discontinued and topical corticosteroid was started as a treatment. Partial healing was obtained after 2 weeks of therapy.</p>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>(A) A moderately bandlike and prominent perivascular lymphocytic infiltration in superficial dermis. (H&#x0026;E, &#x00D7;100), (B) The closer view of infiltration, the pseudovasculitis appearence of lymphocytic infiltration encircling vessels without fibrin deposition (H&#x0026;E, &#x00D7;200), (C,D) The presence of blue coloured hemosiderin within the papillary dermis freely or in macrophage system (Prussian blue, &#x00D7;40).</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-7-112-g002.tif"/>
</fig>
<p>PATM is an uncommon clinical variant of pigmented purpuric dermatosis [<xref ref-type="bibr" rid="ref2">2</xref>]. A variety of diseases had been suggested to be associated with PPD, including Hepatitis B and C infection [<xref ref-type="bibr" rid="ref3">3</xref>]. We consider that the skin eruption of our patient might not occur as a result of Hepatitis B virus, because he was positive for hepatitis B antigen since childhood but the lesions appeared first time two month before, after taking diclofenac sodium tablets.</p>
<p>A wide variety of medications including NSAIDs, diuretics, sedatives, stimulants antibiotics, cardiovascular drugs, vitamins, antihyperglycemics, isotretinoin have been implicated as drugs responsible for the development of PPD [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>]. It was suggested that as a result of antigen-antibody complex deposition in which drugs act as a hapten, an immune system-mediated vascular damage occur and this results in capillary leakage and erythrocyte extravasation [<xref ref-type="bibr" rid="ref5">5</xref>]. The skin eruption of our patient appeared at 10<sup>th</sup> day of oral diclofenac sodium treatment. So, we thought it might be the possible cause of skin eruption in our patient. Also, as in our case, the drug induced cases are more likely to resolve after discontinuation of drug in contrast to chronic or relapsing nature of idiopathic ones [<xref ref-type="bibr" rid="ref5">5</xref>]. Due to possible risk of provocation of a systemic reaction [<xref ref-type="bibr" rid="ref4">4</xref>] we couldn&#x2019;t confirm the diagnoses by oral challenge test or patch test.</p>
<p>We intended to present this case because of the rarity of the PATM and it should be kept in mind that diclofenac sodium could play role in etiopathogenesis.</p>
</sec>
<sec id="sec1-2">
<title>CONSENT</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sardana</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sehgal</surname>
<given-names>VN</given-names>
</name>
</person-group>
<article-title>Pigmented purpuric dermatoses: an overview</article-title>
<source>Int J Dermatol</source>
<year>2004</year>
<volume>43</volume>
<fpage>482</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoesly</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Huerter</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Shehan</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Purpura annularis telangiectodes of Majocchi: case report and review of the literature</article-title>
<source>Int J Dermatol</source>
<year>2009</year>
<volume>48</volume>
<fpage>1129</fpage>
<lpage>33</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dessoukey</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Abdel-Dayem</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Omar</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Al-Suweidi</surname>
<given-names>NE</given-names>
</name>
</person-group>
<article-title>Pigmented purpuric dermatosis and hepatitis profile: a report on 10 patients</article-title>
<source>Int J Dermatol</source>
<year>2005</year>
<volume>44</volume>
<fpage>486</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#237;az-Jara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tornero</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barrio</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Vicente</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Fuentes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Barranco</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Pigmented purpuric dermatosis due to pseudoephedrine</article-title>
<source>Contact Dermatitis</source>
<year>2002</year>
<volume>46</volume>
<fpage>300</fpage>
<lpage>1</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meehan</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Leger</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis</article-title>
<source>JAMA Dermatol</source>
<year>2014</year>
<volume>150</volume>
<fpage>182</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil,</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
